Jaguar Health (JAGX) Gross Profit (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Gross Profit data on file, last reported at $19.1 million in Q1 2026.

• Gross Profit for Q1 2026 came in at $19.1 million, up 1025.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.3 million (up 54.74% YoY), and the FY2025 annual result was $2.3 million, down 76.62% from the prior year.
• Gross Profit improved to $19.1 million in Q1 2026 per JAGX's latest filing, from -$4.4 million in the prior quarter.
• Over five years, Gross Profit peaked at $19.1 million in Q1 2026 and troughed at -$4.4 million in Q4 2025.
• A 5-year average of $2.4 million and a median of $1.2 million in 2024 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2023: Gross Profit soared 7907.69% in 2022, then slumped 322.76% in 2023.
• A 5-year view of Gross Profit shows it stood at $5.1 million in 2022, then tumbled by 68.38% to $1.6 million in 2023, then soared by 304.9% to $6.5 million in 2024, then plunged by 167.77% to -$4.4 million in 2025, then soared by 531.86% to $19.1 million in 2026.
• Business Quant data shows JAGX's Gross Profit at $19.1 million in Q1 2026, -$4.4 million in Q4 2025, and $1.1 million in Q3 2025.